XiaoMi-AI文件搜索系统
World File Search SystemAtlantica
A&M 估值洞察
Ørsted A/S Voltalia SA EDP Renovation, SA Edison SpA Nexans SA Energy Office AG VERBUND AG EnBW Energy Baden-Württemberg AG LEM Holding SA PNE AG Solar Energy and Environment, SA Endesa, SA Ecosuntek SpA Clere AG Enel SpA Arise AB (publ) Energiedienst Holding AG Brookfield Renewable Partners LP EVN AG Atlantica Sustainable Infrastructure plc Fortum Oyj Aega ASA Iberdrola, SA ERG SpA (YieldCo) RWE Joint Stock Company Encavis AG (YieldCo) SSE plc 7C Solarparken AG (YieldCo) Public Power Corporation SA Alerion Clean Power SpA (YieldCo) EDP - Energy as of Portugal, SA clearvise AG (YieldCo) Edisun Power Europe AG (YieldCo) Tion Renewables AG (YieldCo) Greencoat Renewables plc (YieldCo) Octopus Renewables Infrastructure Trust plc (YieldCo)
关键数据公司简介投资组合按行业细分8 ...
Atlantica 是一家可持续基础设施公司，其大部分业务是可再生能源资产。我们以存储、高效天然气和输电基础设施资产作为可再生资产组合的补充，作为向清洁能源结构过渡的推动因素。我们还涉足水基础设施资产，这是可持续发展的核心领域。我们的目标是通过投资和管理可持续基础设施来支持向更可持续的世界过渡，同时为我们的投资者和其他利益相关者创造长期价值。我们目前拥有 39 项资产，包括 2,044 兆瓦的总可再生能源装机发电能力（其中约 71% 为太阳能）、343 兆瓦的高效天然气发电能力、55 兆瓦的区域供热能力、1,229 英里的输电线和每天 17.5 Mft3 的海水淡化。我们目前在北美（美国、加拿大和墨西哥）、南美和欧洲、中东和非洲地区拥有和管理运营设施。我们的资产通常具有合同或受监管的收入。截至 2021 年 12 月 31 日，我们资产的加权平均剩余合同期限约为 15.1 年。
心脏传导异常的表征...
S. Vermeire received grants from AbbVie, Johnson & Johnson, Pfizer, Galapagos, and Takeda and has received consulting and/or speaking fees from AbbVie, AbolerIS Pharma, Agomab, Alimentiv, Arena Pharmaceuticals, AstraZeneca, Avaxia, BMS, Boehringer Ingelheim, Celgene, CVasThera, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, GSK, Hospira, IMIDomics, Janssen, Johnson & Johnson, Lilly, Materia Prima, MiroBio, Morphic, MRM Health, Mundipharma, MSD, Pfizer, ProDigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Surrozen, Takeda, Theravance，Tillotts Pharma Ag和Zealand Pharma。A. Yarur从Takeda，Prometheus Labs，Arena Pharmaceuticals和Bristol Myers Squibb和Bristol Myers Squibb的发言人费用获得了咨询费。D.T.鲁宾已获得武田的赠款支持； has served as a consultant for AbbVie, Abgenomics, Allergan, Boehringer Ingelheim, Bristol Myers Squibb, Celgene Corp/Syneos, Dizal Pharmaceuticals, GalenPharma/Atlantica, Genentech/Roche, Gilead Sciences, Ichnos Sciences S.A., GSK Services, Janssen, Eli Lilly, Pfizer, Prometheus实验室，Reistone，Shire，Takeda和TechLab。M.C. 杜宾斯基收到了Abbvie，Arena，Bristol Myers Squibb，Celgene，Eli Lilly，Genentech，Gilead，Gilead，Janssen，Janssen，Prometheus Labs和Takeda的咨询费，并且是Trellus Health的创始人和股东。 M. regueiro已收到M.C.杜宾斯基收到了Abbvie，Arena，Bristol Myers Squibb，Celgene，Eli Lilly，Genentech，Gilead，Gilead，Janssen，Janssen，Prometheus Labs和Takeda的咨询费，并且是Trellus Health的创始人和股东。M. regueiro已收到